论文部分内容阅读
对19例中晚期胃食道癌,采用由胃镜引导下瘤体内介入放射性药物~(32)P-胶体内照射治疗。经过2~4次治疗完全缓解7例(36.84%7/19),部分缓解9例(47.36%,9/19),无变化1例(5.26%,1/19),有效率为84.10%(16/19);生存期:随访19例至1997年3月底。存活2~5个月2人(10.52%),1年以上17人(89.47%)。作者认为,瘤体内介入放射性药物~(32)P-胶体内照射治疗胃食道癌,方法简便,使用安全,无明显副作用,并对治疗方案,操作方法及治疗敏感性等问题进行了讨论。
For 19 patients with advanced gastroesophageal cancer, intratumoral radiopharmaceuticals (32) P-colloidal radiation therapy were introduced under gastroscope guidance. After 2 to 4 treatments, 7 cases (36.84% 7/19) achieved complete remission, 9 cases (47.36%, 9/19) partially resolved, 1 case (5.26%, 1/19) remained unchanged, and the effective rate was 84.10% ( 16/19); Lifetime: 19 cases were followed up until the end of March 1997. 2 (5.52%) survived for 2 to 5 months and 17 (89.47%) took over 1 year. The authors believe that the intratumoral intervention of radiopharmaceuticals ~ (32) P-colloidal irradiation in the treatment of gastroesophageal cancer, the method is simple, safe to use, no obvious side effects, and treatment options, methods of operation and treatment sensitivity and other issues are discussed.